MA
MASTERCARD INCORPORATED
MAOwnership as of Q2 2026
Funds owning
20
Combined value
4.8B
Avg portfolio %
5.3%
Buys / Sells this quarter
−1 sells
Q2-2026
| Investor | Weight | Q/Q change | Value |
|---|---|---|---|
VF Valley Forge Capital Management – Dev Kantesariaas of Q1-2026 | High conviction 22.02% | ↗Added 0.01% | 1.5M shares · $499.66 $743.2M |
AC Akre Capital Management – Chuck Akreas of Q1-2026 | High conviction 18.64% | ↘Reduced 24.10% | 2.3M shares · $499.66 $1.1B |
AZ Aquamarine Zurich – Guy Spier | Core 14.26% | 40.0K shares · $513.60 $20.5M | |
GR Gardner Russo & Quinn – Thomas Russoas of Q1-2026 | Core 9.15% | ↘Reduced 1.95% | 1.6M shares · $499.66 $777.0M |
TF Triple Frond Partnersas of Q1-2026 | Core 9.11% | ↗Buy | 175.5K shares · $499.66 $87.7M |
AP Altarock Partnersas of Q1-2026 | Core 6.33% | ↘Reduced 3.51% | 522.8K shares · $499.66 $261.2M |
PC Polen Capital Managementas of Q1-2026 | Core 5.33% | ↘Reduced 27.69% | 1.5M shares · $499.66 $770.2M |
WI Weitz Investment Managementas of Q1-2026 | Core 5.13% | ↘Reduced 5.71% | 147.0K shares · $499.66 $73.5M |
VV Vulcan Value Partnersas of Q1-2026 | Core 5.08% | ↘Reduced 14.70% | 383.2K shares · $499.66 $191.5M |
JI Jensen Investment Managementas of Q1-2026 | Trial 4.84% | ↗Added 1.70% | 490.9K shares · $499.66 $245.3M |
EC Egerton Capital | Trial 1.80% | ↘Reduced 20.92% | 363.5K shares · $513.60 $186.7M |
AC Ako Capitalas of Q1-2026 | Trial 1.52% | ↗Added 55.42% | 155.6K shares · $499.66 $77.7M |
MG Markel Group – Tom Gayneras of Q1-2026 | Trial 0.87% | 207.5K shares · $499.66 $103.7M | |
GC Giverny Capitalas of Q1-2026 | Trial 0.51% | ↘Reduced 2.41% | 28.1K shares · $499.66 $14.0M |
LP Lone Pine Capital – Stephen Mandelas of Q1-2026 | Trial 0.23% | ↘Reduced 40.62% | 57.2K shares · $499.66 $28.6M |
YA Yacktman Asset Managementas of Q1-2026 | Trial 0.08% | 11.7K shares · $499.66 $5.8M | |
HA Harris Associatesas of Q1-2026 | Trial 0.08% | ↘Reduced 0.35% | 118.6K shares · $499.66 $59.3M |
SA Semper Augustus Investments Group – Christopher Bloomstranas of Q1-2026 | Trial 0.04% | ↗Buy | 658 shares · $499.78 $328,852 |
BW Brave Warrior Advisors – Glenn Greenbergas of Q1-2026 | Trial 0.01% | 422 shares · $499.66 $210,857 | |
M& Mairs & Poweras of Q1-2026 | Trial 0.00% | ↘Reduced 16.67% | 520 shares · $499.66 $259,823 |
| 20 funds | $4.8B |